Department of First Surgery, Yamagata University Hospital, 2-2-2 Iidanishi, Yamagata-shi, Yamagata-ken, 990-9585, Japan.
Department of Surgery, Sendai Medical Center, 2-11-12 Miyagino, Miyagino-ku, Sendai, Miyagi-ken, 983-8520, Japan.
J Robot Surg. 2022 Feb;16(1):159-168. doi: 10.1007/s11701-021-01216-5. Epub 2021 Mar 16.
We aimed to evaluate the advantages and disadvantages of initial robotic surgery for rectal cancer in the introduction phase. This study retrospectively evaluated patients who underwent initial robotic surgery (n = 36) vs. patients who underwent conventional laparoscopic surgery (n = 95) for rectal cancer. We compared the clinical and pathological characteristics of patients using a propensity score analysis and clarified short-term outcomes, urinary function, and sexual function at the time of robotic surgery introduction. The mean surgical duration was longer in the robot-assisted laparoscopy group compared with the conventional laparoscopy group (288.4 vs. 245.2 min, respectively; p = 0.051). With lateral pelvic lymph node dissection, no significant difference was observed in surgical duration (508.0 min for robot-assisted laparoscopy vs. 480.4 min for conventional laparoscopy; p = 0.595). The length of postoperative hospital stay was significantly shorter in the robot-assisted laparoscopy group compared with the conventional laparoscopy group (15 days vs. 13.0 days, respectively; p = 0.026). Conversion to open surgery was not necessary in either group. The International Prostate Symptom Score was significantly lower in the robot-assisted laparoscopy group compared with the conventional laparoscopy group. Moderate-to-severe symptoms were more frequently observed in the conventional laparoscopy group compared with the robot-assisted laparoscopy group (p = 0.051). Robotic surgery is safe and could improve functional disorder after rectal cancer surgery in the introduction phase. This may depend on the surgeon's experience in performing robotic surgery and strictly confined criteria in Japan.
我们旨在评估引入阶段直肠癌初始机器人手术的优缺点。本研究回顾性评估了接受初始机器人手术(n=36)和常规腹腔镜手术(n=95)治疗直肠癌的患者。我们使用倾向评分分析比较了患者的临床和病理特征,并在机器人手术引入时阐明了短期结果、尿功能和性功能。与常规腹腔镜组相比,机器人辅助腹腔镜组的平均手术时间更长(分别为 288.4 分钟和 245.2 分钟;p=0.051)。对于侧盆淋巴结清扫术,手术时间无显著差异(机器人辅助腹腔镜组为 508.0 分钟,常规腹腔镜组为 480.4 分钟;p=0.595)。与常规腹腔镜组相比,机器人辅助腹腔镜组的术后住院时间明显缩短(分别为 15 天和 13.0 天;p=0.026)。两组均无需转为开放性手术。机器人辅助腹腔镜组的国际前列腺症状评分明显低于常规腹腔镜组。与机器人辅助腹腔镜组相比,常规腹腔镜组更常出现中重度症状(p=0.051)。机器人手术安全,可改善直肠癌手术引入阶段后的功能障碍。这可能取决于外科医生进行机器人手术的经验和日本严格限制的标准。